Be a part of 4^th International Meeting on
Breast Cancer & Therapies

Breast Cancer: It is the most common cancer among women worldwide and is the second leading cause of cancer-related death in women. It can also affect men, though it is much less common. Factors such as age, genetics, hormonal influences, and lifestyle can impact the risk of developing breast cancer. The majority of breast cancers are derived from the cells lining the milk ducts (ductal carcinomas) or the lobules (lobular carcinomas).
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Breast Cancer Therapies & Treatments: Breast cancer treatment has evolved significantly, incorporating a multi-disciplinary approach. The goal is to provide personalized treatment plans based on the specific characteristics of the cancer and the patient's overall health. The landscape of breast cancer treatment is constantly evolving, with new therapies and approaches emerging regularly. By combining traditional treatments with cutting-edge research and supportive care, healthcare providers can offer personalized, effective, and comprehensive care to breast cancer patients.
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Breast Cancer Clinical Trials: Clinical trials are critical to advancing breast cancer treatment, offering insights into the effectiveness and safety of new therapies and improving existing treatment protocols. These research studies involve patients and aim to find better ways to prevent, diagnose, and treat breast cancer. Clinical trials are essential for the ongoing improvement of breast cancer treatment. They offer patients access to new therapies and contribute to the collective understanding of how to best combat this disease. By participating in clinical trials, patients play a crucial role in advancing medical research and improving outcomes for future breast cancer patients.
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Breast Cancer Radiology: Breast cancer remains one of the most prevalent cancers among women worldwide. Early detection is crucial for improving prognosis and survival rates, making radiology a vital component in breast cancer diagnosis and management. Breast cancer radiology is a dynamic field that significantly contributes to the early detection and effective management of breast cancer. Continued advancements in technology, coupled with a focus on personalized medicine and patient-centred care, are essential for improving outcomes and reducing disparities in breast cancer care.
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Breast Cancer during Pregnancy: Breast cancer is one of the most common cancers affecting women, and its occurrence during pregnancy, though rare, presents unique challenges. Diagnosing and treating breast cancer in pregnant women requires a careful balance between the health of the mother and the safety of the developing foetus. Continued research and awareness are crucial for improving care and support for pregnant women facing breast cancer.
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Breast Cancer Surgery: Surgery is a cornerstone in the treatment of breast cancer, aiming to remove cancerous tissue while conserving as much healthy tissue as possible. Breast cancer surgery is a critical step in the treatment journey, offering the best chance for removing cancer and preventing recurrence. With advancements in surgical techniques and a multidisciplinary approach, the outcomes for breast cancer patients continue to improve. Understanding the process, preparing adequately, and adhering to post-operative care are essential for achieving optimal results and enhancing the quality of life for breast cancer patients.
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Male Breast Cancer: Male breast cancer, though rare, is a significant health concern. It accounts for less than 1% of all breast cancer cases. Due to its rarity, male breast cancer often lacks awareness, leading to later-stage diagnoses. Understanding the risk factors, recognizing symptoms, and seeking timely medical attention are crucial. Advances in treatment have improved prognosis, and a multidisciplinary approach ensures comprehensive care. Ongoing research and awareness efforts are essential to further improve the diagnosis, treatment, and survival rates for male breast cancer patients.
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Metastatic Breast Cancer: Metastatic breast cancer, also known as stage IV breast cancer, occurs when cancer cells spread beyond the breast to other parts of the body. This advanced stage of cancer is not curable, but it is treatable. The focus of treatment is on controlling the disease, alleviating symptoms, and improving quality of life. Metastatic breast cancer presents significant challenges, but with appropriate treatment and support, many patients can manage the disease and maintain a good quality of life.
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Breast Pathology: Treatment and Drugs: Breast pathology encompasses a range of conditions affecting the breast, including benign lesions and malignant tumours. Treatment strategies and drug therapies vary based on the specific type and stage of the disease. Advancements in medical therapies, including surgery, radiation, chemotherapy, hormone therapy, targeted therapy, and immunotherapy, have significantly improved outcomes for patients with breast pathology. Individualized treatment plans tailored to the specific type and stage of breast pathology are crucial for optimizing patient outcomes and quality of life.
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Chemotherapy for Breast Cancer: Chemotherapy is a cornerstone of breast cancer treatment, involving the use of drugs to destroy cancer cells. It can be used at various stages of breast cancer and is often combined with other treatment modalities such as surgery, radiation, and targeted therapy. Advances in supportive care continue to enhance the tolerability and effectiveness of chemotherapy, offering hope and better quality of life for those undergoing treatment.
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Prevention of Breast Cancer: Breast cancer prevention involves adopting lifestyle changes, understanding and managing risk factors, and considering medical interventions when appropriate. While not all cases of breast cancer can be prevented, these strategies can significantly reduce the risk and aid in early detection. awareness and proactive management of risk factors are key components in the fight against breast cancer.
Related Societies:
National Breast Cancer Foundation | Korean Breast Cancer Society | European Cancer Organisation | American Cancer Society | Singapore Cancer Society | UK Oncology Nursing Society

Breast Cancer Therapeutics Market size was around USD 26.7 billion in 2022 and is expected to reach USD 54.7 billion by 2032. The growing incidence of breast cancer is amongst the major factors stimulating the market growth.

The Breast Cancer Therapy Market is Segmented by Therapy (Radiation Therapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers market sizes and forecasts in terms of value (USD million) for the above segments.

The major factors fueling the market's growth are the high incidence and prevalence rates of breast cancer, increasing investment in research and development, and advancements in cancer biology and pharmacology, promoting drug development.

Meetings Int. is a worldwide pioneer in delivering top-notch gatherings, workshops, and symposia in every significant field of science, innovation, and medication worldwide receiving 400,000+ online visitors with 1000+ sessions which confirms an outstanding pool of new users and visitors creating a platform to build your market place globally. Since its initiation, Meetings Int. has been related to national and global affiliations, organizations, and elevated-level people, committed to having world-class meetings and occasions so it provides a big platform to show your product and advertising. The Explorer’s traffic is the benchmark for advertisement, and the Breast Cancer Conference website is continually dragged worldwide. As specified by Google Analytics, in excess of 12,836 researchers and industrials are visiting our conference sites. Breast Cancer 2025 seminar helps you put the spotlight on your brand by advertising with more than 9 million+ readers worldwide about 5 million+ hits every month on our site. We provide an excellent opportunity to boost your business on our platform. We offer a range of eye-catching advertising spaces and branding. Researchers from powerful nations including the United States, Japan, United Kingdom, India, France, Taiwan, and Germany, etc.  Visit our conference site. Subscribers and conference attendees can be your upcoming enthusiastic customers. We maintain high quality and ethical standards in the event industry, which makes us unique and better than the rest. Advertisement banners must be provided by the advertising company and in jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.  You can also Contact us:

Contact Person: Emily Griffin
Contact Email: contact@meetingsint.com

We are announcing the Young Scientist Awards through the 4th International Meeting on Breast Cancer & Therapies which is scheduled on March 17-18, 2025 in Singapore. This Breast Cancer 2025 focuses on “Exploring the New trends and Horizons of Breast Cancer Research.

Breast Cancer 2025 and upcoming conferences will recognize participants who have significantly added value to the scientific community of Medical science and provide them with outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researchers by meeting experts to exchange and share their experiences at our international conferences.
Breast Cancer 2025 operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, Ph.D. students, and trainees to showcase their research and innovation.
Eligibility: Young Scientists, faculty members, post-doctoral fellows, Ph.D. scholars, and bright Final Year MSc and M.Phil. Candidates and Persons from Scientific Industry can also participate.

Benefits:
The Young Scientist Feature is a platform to promote young researchers in their respective areas by giving them a chance to present their achievements and future perspectives.
Acknowledgment as YRF Awardee
Promotion on the conference website, Young Scientist Awards and certificates

• Link on the conference website
• Recognition on Meetings Int. Award Page
• Chances to coordinate with partners around the world
• Research work can be published in the relevant journal without any publication fee

Criteria:

• All presented abstracts will automatically be considered for the Award.
• All the presentations will be evaluated in the conference venue.
• All the awards will be selected by the judges of the award category.
• The winners of the Young Scientist Award will receive an award certificate.
• The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

• All submissions must be in English.
• The topic must fit into the scientific sessions of the conference
• Each individual participant is allowed to submit maximum 2 papers
• The abstract must be submitted online as per the given abstract template
• Abstracts must be written in Times New Roman and font size will be 12
• The abstract must contain the title, name, affiliation, country, speaker’s biography, recent photograph, image, and reference

Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication on the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of the award.
Award Announcements:
The official announcement of the recipients will occur after the completion of Breast Cancer 2025

Meetings International has taken an initiative to felicitate attendees with awards to recognise, celebrate and encourage achievement in its various conferences and events. We salute and acknowledge attainment within an industry that is continuously evolving and re-drawing the boundaries of best practices. These awards represent the pinnacle of professional achievement for event professionals. To win an award you will have been endorsed by our illustrious panel of the foremost industry professionals which is a sure-fire signifier of your formidable credentials.

Outstanding Speaker in Breast Cancer 2025: This award recognizes academic and business speakers for their excellent presentation skills and for the significant contribution in Breast Cancer & Therapy that they make to their professions, their teams, and their patients through their practice, leadership, or research endeavour. The recipient of this award will be chosen by the session chair and co-chair. The awardees will be felicitated after the completion of the oral session. Our Breast Cancer Conference encourages researchers from across the globe to take part as a speaker at these prestigious events.

Best Keynote Speaker in Breast Cancer 2025: This award recognizes the notable presentations given during the course of the Breast Cancer conference. It also recognizes the enthusiasm and determination of the speaker to improve the experience of all who they come into contact with. The award will be given based on the impact of the presentation on the attendees of the event. We will also be taking into account the references taken from the citations of the keynote speaker. These awardees will be felicitated by one of the members of the organizing panel present during the conference.

Best Organising Committee Member in Breast Cancer 2025: This award seeks to recognize the continuous support provided by the Organising Committee members of the conference. The recipient of this award will be selected by the operating committee of Breast Cancer 2025. The award will be given based on the support and cooperation provided by a member of the organizing panel from the beginning to the successful completion of the conference.

Outstanding Masters/Ph.D./Postdoc Thesis work presentation in Breast Cancer 2025: This award seeks to recognize the young brains of the current era. The recipient of this award will be selected by the judge of the Young Researchers Forum. This award will be given based on the presentation skills, impact of research, and its applications in the Breast Cancer field. Participants pursuing Masters, Ph.D. or Post-Doctoral studies are eligible for this award. The awardees will be felicitated after the completion of all the oral presentations delivered under the Young Researchers Forum category.

Best Poster Award in Breast Cancer 2025:  This award recognizes the best poster presentation given during the course of an event. The recipient of this award will be selected by the judge of the poster session. An award-winning poster will be evaluated on presentation content and clarity, innovativeness of approach, communication criteria, and scientific aspects. It will also be based on layout, Breast Cancer research insights, and analysis and results from the description. The awardees will be felicitated after the completion of the poster session.

The honors are given for our Breast Cancer conferences to perceive the wide scope of obligations and commitment of Breast Cancer who advance the quickest improvements and inventive practices in the field of Breast Cancer research. It makes an immense commitment to surpass the research practices and introduce new insights into Breast Cancers to the globe. 

 Criteria:

• All presented abstracts will automatically be considered for the Award.
• All the awards will be selected by the judges of the award category.
• The winners will be formally announced during the closing ceremony.
• The winners of the Poster Award will receive an award certificate.
• The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

• All submissions must be in English.
• The topic must fit into the scientific sessions of the conference.
• Each individual participant is allowed to submit maximum 2 papers.
• The abstract must be submitted online as per the given abstract template.
• Abstracts must be written in Times New Roman and font size will be 12.
• The abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference.
• Each poster should be approximately 1x1 M long. The title, contents, and the author’s information should be clearly visible from a distance of 1-2 feet.